Phase 2 Lymphoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are willing to participate and are able to sign a consent form after fully understanding the study.
• People aged 18 or older, of any gender.
• People who have been diagnosed through laboratory testing with a specific type of lymphoma called CD5-positive DLBCL (Diffuse Large B-Cell Lymphoma).
• People who have at least one area of lymphoma that can be measured or assessed using standard lymphoma guidelines.
• People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scoring system (confirm with trial site).
• People whose life expectancy is at least 3 months.
• People whose bone marrow, liver, and kidney are functioning well enough to meet the trial's requirements.

Who may not be able to join:

• People whose DLBCL exists alongside another type of lymphoma, or whose lymphoma has transformed from a different type.
• People whose lymphoma has spread to the central nervous system (the brain or spinal cord).
• People who have previously been treated with a type of medicine called a BTK inhibitor.
• People who have a medical reason why they cannot take any of the medicines used in this treatment combination.
• People living with HIV or AIDS.
• People who have difficulty swallowing tablets, or who have a condition that affects how the body absorbs medicines through the digestive system.
• Women who are pregnant or breastfeeding, or people of childbearing age who are not willing to use contraception during the study.
• People with a mental illness or those who are otherwise unable to give informed consent.
• People whom the trial investigators determine are not appropriate candidates for the study for other reasons.

Important: Always verify eligibility with the trial site directly before applying.